Bromo-Nitrile Cyclization for Ipatasertib Intermediate Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, such as (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine, are inefficient due to the need for iodination steps, use of iodide-containing reagents, and harsh reaction conditions, which are costly and environmentally unfriendly, and require multiple isolation steps, leading to increased energy consumption and potential for unwanted byproduct formation.
Innovation Solution
The process involves a cyclization reaction using a bromo-nitrile substituted compound, eliminating the need for iodination, allowing for the use of a more reactive brominating agent and harsher conditions, and enabling through-process steps to reduce the number of isolation steps and overall production cycle duration, while also allowing for the removal of volatile byproducts through distillation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If iodination steps and iodide-containing reagents are used in the preparation process, then the synthesis can proceed through established pathways, but the process becomes costly and environmentally unfriendly
Solution Approach 1:
The patent changes the chemical parameters by substituting iodine-based reagents with bromine-based reagents. This parameter change maintains the synthetic pathway reliability while eliminating the environmental and cost issues associated with iodine. The bromination process achieves the same cyclization objective without the harmful effects of iodide-containing reagents.
2Manufacturing precision
If multiple isolation steps are implemented to ensure product purity, then unwanted byproducts are removed, but energy consumption increases and production time extends
Solution Approach 1:
The patent extracts and removes the need for multiple isolation steps by designing a synthesis pathway that inherently produces fewer byproducts. The bromination-cyclization process directly yields the desired product with minimal impurities, allowing for a simplified workflow that maintains high purity without requiring repeated isolation and purification operations.
Solution Approach 2:
The patent implements a continuous synthesis process where the bromination and cyclization occur in sequence without interruption. This continuous action eliminates the need for intermediate isolation steps, maintaining product purity while reducing energy consumption and production time. The process flows continuously from reactants to final product with minimal interruption.
3Manufacturing precision
If multiple isolation steps are performed to separate byproducts, then product purity is maintained, but the production cycle duration increases
Solution Approach 1:
The patent extracts the unnecessary isolation steps from the production process by employing a bromination-based cyclization that generates minimal byproducts. This approach maintains product purity while eliminating time-consuming separation operations, thereby shortening the overall production cycle.
4Productivity
If harsh reaction conditions are applied to achieve complete conversion, then reaction efficiency improves, but unwanted byproduct formation increases
Solution Approach 1:
The patent changes the reaction parameters by using bromine-based reagents under optimized conditions that achieve complete conversion without excessive harshness. This parameter optimization maintains high reaction efficiency while minimizing byproduct formation through controlled bromination and cyclization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a more cost-effective, environmentally friendly, and efficient production of (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds with reduced impurities and energy consumption, achieving higher yields and shorter production cycles compared to traditional methods.
Implementation Method 1
brominating agent and brominating the pyrimidine compound formed in the cyclization reaction step
Implementation Method 2
removal of volatile byproducts formed in the cyclization reaction step, or in subsequent reaction steps, by distillation
Data Source
AI summary
The present disclosure relates to processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, and more particularly relates to processes for preparing (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d] pyrimidin-4-yl)piperazine and N-protected derivatives thereof, which may be used as an intermediate in the synthesis of Ipatasertib (i.e., (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)-propan-1-one). The present disclosure additionally relates to various compounds that are intermediates employed in these processes.